Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Journal of Cancer Research and Clinical Oncology|April 4, 2023
Invasiveness assessment by artificial intelligence against intraoperative frozen section for pulmonary nodules ≤ 3 cmZe-Rui Zhao, Ying-Hong Yu, Zhi-Chao Lin, et al.Elife|November 14, 2015
The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollutionGui-Zhen Wang, Xin Cheng, Bo Zhou, et al.Frontiers in Oncology|June 2, 2020
Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation TherapyQiu-Zi Zhong, Liu-Hua Long, An Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2020
Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From ChinaShu-Lian Wang, Hui Fang, Chen Hu, et al.JAMA Network Open|November 30, 2021
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical TrialNing Li, Yuan Zhu, Lu-Ying Liu, et al.Cancer Reports (Hoboken, N.J.)|March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphomaJia-Xin Liu, Xin Liu, Yong Yang, et al.Leukemia|September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) studyYong Yang, Ying Wang, Xin Liu, et al.American Journal of Hematology|May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group studyShu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.Blood Advances|July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCGShu-Nan Qi, Yong Yang, Yu-Qin Song, et al.Leukemia|March 11, 2020
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-makingSi-Ye Chen, Yong Yang, Shu-Nan Qi, et al.Pageof 4